Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Transfer of Cellular and Humoral Anti-Tumor Immunity with Immune T Cells After Stem Cell Transplant (SCT) for Metastatic Breast Cancer Following “Vaccination” with Anti-CD3 x Anti-Her2/Neu Bispecific Antibody (Her2Bi) Armed Activated T Cells

Archana Thakur, PhD, Zaid Al-Kadhimi, MD, Cassara Pray, BS, Elyse N. Tomaszewski, BA, Ritesh Rathore, MD, Patricia A. Steele, RN, BSN, Muneer H. Abidi, MD, Lois Ayash, MD, Dana L Schalk, BS, MBA, Karen Myers, BSN, OCN, Alice Mitchell, BS, Abhinav Deol, MD, Joseph P. Uberti, MD, PhD, Voravit Ratanatharathorn, MD, Lawrence G Lum, MD, DSc

Blood (2011) 118 (21): 1914.

https://doi.org/10.1182/blood.V118.21.1914.1914

Published: 2011

Journal Articles

Paraneoplastic Pemphigus (PNP) As a Presenting Finding in a Patient with Hodgkin's Lymphoma

Philip Marjon, MD, Byung Kim, MD, Tamara Lazic, MD, Christina Cernik, MD, Ritesh Rathore, MD

Blood (2011) 118 (21): 4864.

https://doi.org/10.1182/blood.V118.21.4864.4864

Published: 2011

Journal Articles

Induction of Immune Responses and Improved Survival after Infusions of T Cells Armed with Anti-CD3 X Anti-Her2/ Neu Bispecific Antibody in Stage IV Breast Cancer Patients (Phase I).

Lawrence G. Lum, MD, DSC, Ritesh Rathore, MD, Don Dizon, MD, Ding Wang, MD, Zaid Al-Kadhimi, MD, Immunotherapy Team Roger Williams Hospital, Joseph P. Uberti, MD, PhD, Voravit Ratanatharathorn, MD

Blood (2007) 110 (11): 2747.

https://doi.org/10.1182/blood.V110.11.2747.2747

Published: 2007

Journal Articles

The Haploimmunostorm Syndrome: A Distinct Clinical Entity Seen in HLA-Haploidentical Cellular Immunotherapy.

Gerald A. Colvin, DO, Samuel Chung, MD, Eric S. Winer, MD, Mehrdad Abedi, MD, Ritesh Rathore, MD, Lawrence G. Lum, MD, Peter J. Quesenberry, MD

Blood (2006) 108 (11): 2978.

https://doi.org/10.1182/blood.V108.11.2978.2978

Published: 2006

Journal Articles

Dose Dense Dreifach* Melphalan100 for Multiple Myeloma.

David Berz, MD, Elise M. McCormack, MD, Eric S. Winer, MD, Patricia Karwan, RNP, Gerald Colvin, DO, Ritesh Rathore, MD, Larry Lum, MD, Mehrdad Abedi, MD, Gerald Elfenbein, MD, Peter J. Quesenberry, MD

Blood (2006) 108 (11): 5465.

https://doi.org/10.1182/blood.V108.11.5465.5465

Published: 2006

Journal Articles

Infusions of T Cells Armed with Anti-CD3 x Anti-Her2/neu Bispecific Antibody Modulate In Vivo Patient Immune Responses in Phase I Clinical Trials for Breast and Hormone Refractory Prostate Cancers.

Pamela A. Davol, MEd, Jonathan M. Gall, BS, Ryan C. Grabert, BS, Wendy B. Young, RN, OCN, Francis J. Cummings, MD, Ritesh Rathore, MD, Gerald A. Colvin, DO, Gerald J. Elfenbein, MD, Lawrence G. Lum, MD, DSc

Blood (2004) 104 (11): 1349.

https://doi.org/10.1182/blood.V104.11.1349.1349

Published: 2004

Journal Articles

Mini-Haploidentical Transplantation for Refractory Acute Myeloid Leukemia.

Gerald A. Colvin, DO, Mehrdad Abedi, MD, Ritesh Rathore, MD, Lawrence G. Lum, MD, Karen K. Ballen, MD, Bimalangshu Dey, MD, Gerald J. Elfenbein, MD, Peter J. Quesenberry, MD

Blood (2004) 104 (11): 2150.

https://doi.org/10.1182/blood.V104.11.2150.2150

Published: 2004

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Transfer of Cellular and Humoral Anti-Tumor Immunity with Immune T Cells After Stem Cell Transplant (SCT) for Metastatic Breast Cancer Following “Vaccination” with Anti-CD3 x Anti-Her2/Neu Bispecific Antibody (Her2Bi) Armed Activated T Cells

Paraneoplastic Pemphigus (PNP) As a Presenting Finding in a Patient with Hodgkin's Lymphoma

Induction of Immune Responses and Improved Survival after Infusions of T Cells Armed with Anti-CD3 X Anti-Her2/ Neu Bispecific Antibody in Stage IV Breast Cancer Patients (Phase I).

The Haploimmunostorm Syndrome: A Distinct Clinical Entity Seen in HLA-Haploidentical Cellular Immunotherapy.

Dose Dense Dreifach* Melphalan100 for Multiple Myeloma.

Infusions of T Cells Armed with Anti-CD3 x Anti-Her2/neu Bispecific Antibody Modulate In Vivo Patient Immune Responses in Phase I Clinical Trials for Breast and Hormone Refractory Prostate Cancers.

Mini-Haploidentical Transplantation for Refractory Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Update search

Transfer of Cellular and Humoral Anti-Tumor Immunity with Immune T Cells After Stem Cell Transplant (SCT) for Metastatic Breast Cancer Following “Vaccination” with Anti-CD3 x Anti-Her2/Neu Bispecific Antibody (Her2Bi) Armed Activated T Cells

Paraneoplastic Pemphigus (PNP) As a Presenting Finding in a Patient with Hodgkin's Lymphoma

Induction of Immune Responses and Improved Survival after Infusions of T Cells Armed with Anti-CD3 X Anti-Her2/ Neu Bispecific Antibody in Stage IV Breast Cancer Patients (Phase I).

The Haploimmunostorm Syndrome: A Distinct Clinical Entity Seen in HLA-Haploidentical Cellular Immunotherapy.

Dose Dense Dreifach* Melphalan100 for Multiple Myeloma.

Infusions of T Cells Armed with Anti-CD3 x Anti-Her2/neu Bispecific Antibody Modulate In Vivo Patient Immune Responses in Phase I Clinical Trials for Breast and Hormone Refractory Prostate Cancers.

Mini-Haploidentical Transplantation for Refractory Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only